{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:08:19Z","timestamp":1780531699518,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To determine the functional and anatomical outcomes at 12 months after pars plana vitrectomy (PPV) for epiretinal membrane (ERM) and the independent prognostic value of preoperative biomarkers in optical coherence tomography (OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five-year analytical study of 340 eyes with ERM in stages (Govetto G2\u20134). Best-corrected visual acuity (BCVA) logMAR and OCT were evaluated at baseline, 1, 3, 6, and 12 months. The primary objective was to determine the change in BCVA at 12 months (\u0394logMAR 12\u00a0m \u2013 baseline). Univariate tests, ANCOVA, longitudinal mixed linear models, and logistic regression were applied for gain\u2009\u2265\u20090.2 logMAR. The models were adjusted for baseline VA, age, sex, aetiology, surgical technique, and analysis of biomarkers in OCT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Baseline VA was 0.54\u2009\u00b1\u20090.44 logMAR (approximate Snellen equivalent: 20\/70); distribution according to G2 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009166), G3 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009146), G4 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200928). VA improved significantly at 12 months (Wilcoxon\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), equivalent to 11\u201312 ETDRS letters. Secondary ERMs showed greater unadjusted gain than idiopathic ones, but aetiology was not an independent predictor after adjustment. The surgical technique was not independently associated with VA at 12 months (\u03b2=+0.031 logMAR; 95% CI;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.408) or with responder status (OR 1.18; 95% CI;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.625). By severity, advanced stages had worse baseline visual acuity (VA) and greater absolute gains (Kruskal\u2013Wallis H\u2009=\u20097.61;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0223), although with lower final VA compared to lesser stages. Baseline VA was the dominant predictor in all models (\u03b2=\u22120.766; 95% CI;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Among preoperative biomarkers, COST line disruption independently increased the probability of response (OR\u2009=\u20092.08; 95% CI;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013). DRIL, EZ disruption, and central bouquet alterations did not reach significance after adjustment. Mixed models confirmed early improvement, maintained up to 12 months. Kaplan\u2013Meier showed faster time to response in advanced stages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PPV for ERM achieves significant improvement at 12 months. Baseline VA is the main determinant of prognosis. According to Govetto\u2019s classification, the greatest gain occurs in advanced stages, but with lower final VA. The COST line emerges as the only preoperative biomarker with independent prognostic value for achieving\u2009\u2265\u20090.2 logMAR; the others provide limited utility when baseline VA is considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00853-y","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:35:57Z","timestamp":1776774957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgical prognosis in epiretinal membrane: 12-month outcomes after membrane peeling in a 5-year cohort with OCT biomarkers"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1326-8511","authenticated-orcid":false,"given":"Piero","family":"Barrera-Arshavin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Bofill-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Bayo-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Urrejola-Irarrazabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Camelio-Opazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Verdaguer-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Rivas-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Filsecker-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Manuel","family":"L\u00f3pez-Astaburuaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Zachar\u00edas-Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Orellana-Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efra\u00edn","family":"P\u00e9rez-Argando\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"9","key":"853_CR1","doi-asserted-by":"publisher","first-page":"e014644","DOI":"10.1136\/bmjopen-2016-014644","volume":"7","author":"W Xiao","year":"2017","unstructured":"Xiao W, Chen X, Yan W, Zhu Z, He M. Prevalence and risk factors of epiretinal membranes: a systematic review and meta-analysis of population-based studies. BMJ Open. 2017 Sep 25;7(9):e014644.","journal-title":"BMJ Open 25 September"},{"issue":"2","key":"853_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4274\/tjo.galenos.2021.09258","volume":"52","author":"P Kunavisarut","year":"2022","unstructured":"Kunavisarut P, Supawongwattana M, Patikulsila D, Choovuthayakorn J, Watanachai N, Chaikitmongkol V. Idiopathic epiretinal membranes: visual outcomes and prognostic factors. Turk J Ophthalmol. 2022 April 28;52(2):109\u201318. https:\/\/doi.org\/10.4274\/tjo.galenos.2021.09258.","journal-title":"Turk J Ophthalmol 28 April"},{"issue":"3","key":"853_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ceo.13914","volume":"49","author":"AT Fung","year":"2021","unstructured":"Fung AT, Galvin J, Tran T. Epiretinal membrane: a review. Clin Exp Ophthalmol. 2021;49(3):289\u2013308. https:\/\/doi.org\/10.1111\/ceo.13914.","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"853_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0161-6420(97)30190-0","volume":"104","author":"P Mitchell","year":"1997","unstructured":"Mitchell P, Smith W, Chey T, Wang JJ, Chang A. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology. 1997;104(6):1033\u201340. https:\/\/doi.org\/10.1016\/s0161-6420(97)30190-0.","journal-title":"Ophthalmology"},{"issue":"4","key":"853_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.ophtha.2010.08.009","volume":"118","author":"CH Ng","year":"2011","unstructured":"Ng CH, Cheung N, Wang JJ, et al. Prevalence and risk factors for epiretinal membranes in a multi-ethnic United States population. Ophthalmology. 2011;118(4):694\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2010.08.009.","journal-title":"Ophthalmology"},{"issue":"1","key":"853_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0161-6420(02)01443-4","volume":"110","author":"S Fraser-Bell","year":"2003","unstructured":"Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology. 2003;110(1):34\u201340. https:\/\/doi.org\/10.1016\/s0161-6420(02)01443-4.","journal-title":"Ophthalmology"},{"issue":"3","key":"853_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s10384-018-0581-x","volume":"62","author":"A Tanikawa","year":"2018","unstructured":"Tanikawa A, Shimada Y, Horiguchi M. Comparison of visual acuity, metamorphopsia, and aniseikonia in patients with an idiopathic epiretinal membrane. Jpn J Ophthalmol. 2018;62(3):280\u20135. https:\/\/doi.org\/10.1007\/s10384-018-0581-x.","journal-title":"Jpn J Ophthalmol"},{"issue":"11","key":"853_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamaophthalmol.2020.3328","volume":"138","author":"SR Hatt","year":"2020","unstructured":"Hatt SR, Leske DA, Iezzi R Jr, Holmes JM. Binocular interference vs diplopia in patients with epiretinal membrane. JAMA Ophthalmol. 2020;138(11):1121\u20137. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3328.","journal-title":"JAMA Ophthalmol"},{"key":"853_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2147\/OPTH.S97722","volume":"10","author":"W Stevenson","year":"2016","unstructured":"Stevenson W, Prospero Ponce CM, Agarwal DR, Gelman R, Christoforidis JB. Epiretinal membrane: optical coherence tomography-based diagnosis and classification. Clin Ophthalmol. 2016;10:527\u201334. Published 29 March 2016. https:\/\/doi.org\/10.2147\/OPTH.S97722.","journal-title":"Clin Ophthalmol"},{"key":"853_CR10","doi-asserted-by":"crossref","unstructured":"Mahmoudzadeh R, Israilevich R, Salabati M, Hsu J, Garg S, Regillo C, Ho A, Khan M. Pars plana vitrectomy for idiopathic epiretinal membrane: optical coherence tomography biomarkers of visual outcomes in 322 eyes. Ophthalmology. Retina. 2021.","DOI":"10.1016\/j.oret.2021.10.008"},{"key":"853_CR11","volume-title":"Epiretinal Membrane Surgery in Eyes with Glaucoma: Visual Outcomes and Clinical Significance of Inner Microcystoid Changes","author":"T Peck","year":"2022","unstructured":"Peck T, Salabati M, Mahmoudzadeh R, Soares R, Xu D, Myers J, Hsu J, Garg S, Khan M. Epiretinal membrane surgery in eyes with glaucoma: visual outcomes and clinical significance of inner microcystoid changes. Retina: Ophthalmol. 2022."},{"key":"853_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000541425","volume":"248","author":"C Leisser","year":"2024","unstructured":"Leisser C, Schlatter A, Ruiss M, Pilwachs C, Findl O. Changes of optical coherence tomography biomarkers after peeling of epiretinal membranes. Ophthalmologica. 2024;248:1\u201310.","journal-title":"Ophthalmologica"},{"key":"853_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2016.12.006","volume":"175","author":"A Govetto","year":"2017","unstructured":"Govetto A, Lalane RA 3rd, Sarraf D, Figueroa MS, Hubschman JP. Insights into epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme. Am J Ophthalmol. 2017;175:99\u2013113. https:\/\/doi.org\/10.1016\/j.ajo.2016.12.006.","journal-title":"Am J Ophthalmol"},{"key":"853_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12886-025-03889-0","volume":"25","author":"J Li","year":"2025","unstructured":"Li J, Cheng F, Li Z, et al. Assessment of clinical outcomes and prognostic factors following membrane peeling in idiopathic epiretinal membrane using EIFL staging system: an optical coherence tomography angiography analysis. BMC Ophthalmol. 2025;25:54. https:\/\/doi.org\/10.1186\/s12886-025-03889-0.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"853_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/IAE.0000000000001940","volume":"39","author":"A Govetto","year":"2019","unstructured":"Govetto A, Virgili G, Rodriguez FJ, Figueroa MS, Sarraf D, Hubschman JP. Functional and anatomical significance of the ectopic inner foveal layers in eyes with idiopathic epiretinal membranes: Surgical Results at 12 Months. Retina. 2019;39(2):347\u201357. https:\/\/doi.org\/10.1097\/IAE.0000000000001940.","journal-title":"Retina"},{"issue":"10","key":"853_CR16","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1007\/s10792-022-02317-2","volume":"42","author":"RS Patheja","year":"2022","unstructured":"Patheja RS. Preoperative ocular coherence tomographic prognosticators of visual acuity after idiopathic epiretinal membrane surgery. Int Ophthalmol. 2022;42(10):3243\u201352. https:\/\/doi.org\/10.1007\/s10792-022-02317-2.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"853_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/2474126421989614","volume":"5","author":"IS Dimopoulos","year":"2021","unstructured":"Dimopoulos IS, Dollin M. Inner retinal morphology and visual outcomes in idiopathic epiretinal membrane surgery: a retrospective optical coherence tomography study. J Vitreoretin Dis. 2021;5(6):488\u201394. Published 24 February 2021. https:\/\/doi.org\/10.1177\/2474126421989614.","journal-title":"J Vitreoretin Dis"},{"issue":"11","key":"853_CR18","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3928\/23258160-20181101-04","volume":"49","author":"T Sato","year":"2018","unstructured":"Sato T, Mori R, Takahashi S, et al. Retrospective comparison of visual prognosis after vitrectomy for idiopathic epiretinal membranes with and without an ectopic inner foveal layer. Ophthalmic Surg Lasers Imaging Retina. 2018;49(11):838\u201345. https:\/\/doi.org\/10.3928\/23258160-20181101-04.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"2","key":"853_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/IAE.0000000000003306","volume":"42","author":"TS Tuifua","year":"2022","unstructured":"Tuifua TS, Abraham JR, Srivastava SK, Kaiser PK, Reese J, Ehlers JP. Longitudinal ellipsoid zone and outer retinal integrity dynamics after epiretinal membrane surgery. Retina. 2022;42(2):265\u201373. https:\/\/doi.org\/10.1097\/IAE.0000000000003306.","journal-title":"Retina"},{"key":"853_CR20","doi-asserted-by":"crossref","unstructured":"Zur D, et al. Disorganisation of retinal inner layers as a biomarker for idiopathic epiretinal membrane after macular surgery\u2014the DREAM study. Am J Ophthalmol. 196:129\u201335.","DOI":"10.1016\/j.ajo.2018.08.037"},{"issue":"8","key":"853_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137. PMID: 17938396.","journal-title":"Ann Intern Med"},{"issue":"3","key":"853_CR22","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities hand motion and counting fingers can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236\u201340.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"853_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","volume":"247","author":"C Lange","year":"2009","unstructured":"Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories hand motion and counting fingers using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137\u201342.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"853_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ajo.2017.10.011","volume":"184","author":"A Govetto","year":"2017","unstructured":"Govetto A, Bhavsar KV, Virgili G, Gerber MJ, Freund KB, Curcio CA, et al. Tractional abnormalities of the central foveal bouquet in epiretinal membranes: clinical spectrum and pathophysiological perspectives. Am J Ophthalmol. 2017;184:167\u201380. https:\/\/doi.org\/10.1016\/j.ajo.2017.10.011.","journal-title":"Am J Ophthalmol"},{"key":"853_CR25","unstructured":"The Jamovi Project. jamovi. (Version 2.6) [Computer Software]. 2024. Retrieved from https:\/\/www.jamovi.org."},{"key":"853_CR26","unstructured":"R Core Team. (2024). R: A Language and environment for statistical computing. (Version 4.4) [Computer software]. Retrieved from https:\/\/cran.r-project.org. (R packages retrieved from CRAN snapshot 2024-08-07)."},{"key":"853_CR27","doi-asserted-by":"publisher","unstructured":"De Clerck I, Zeyen A, Sierens L, Cornelis S, Van Calster J, Jansen J, Stalmans P. Surgical outcomes, validation of Govetto staging, and postsurgical macular oedema in idiopathic epiretinal membranes: a large retrospective study. Retina. 2025 Oct;45(10):1878\u20131885. https:\/\/doi.org\/10.1097\/IAE.0000000000004559.","DOI":"10.1097\/IAE.0000000000004559"},{"issue":"2","key":"853_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4274\/tjo.galenos.2021.09258","volume":"52","author":"P Kunavisarut","year":"2022","unstructured":"Kunavisarut P, Supawongwattana M, Patikulsila D, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Pathanapitoon K, Rothova A. Idiopathic epiretinal membranes: visual outcomes and prognostic factors. Turkish J Ophthalmol. 2022;52(2):109\u201318. https:\/\/doi.org\/10.4274\/tjo.galenos.2021.09258.","journal-title":"Turkish J Ophthalmol"},{"key":"853_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40942-023-00496-3","volume":"9","author":"VA Englmaier","year":"2023","unstructured":"Englmaier VA, Storp JJ, Eter N, et al. Short-term outcomes of idiopathic epiretinal membranes treated with pars plana vitrectomy \u2013 examination of visual function and OCT morphology. Int J Retin Vitr. 2023;9:55. https:\/\/doi.org\/10.1186\/s40942-023-00496-3.","journal-title":"Int J Retin Vitr"},{"issue":"4","key":"853_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1442-9071.2005.01025.x","volume":"33","author":"JG Wong","year":"2005","unstructured":"Wong JG, Sachdev N, Beaumont PE, Chang AA. Visual outcomes following vitrectomy and peeling of epiretinal membrane. Clin Exp Ophthalmol. 2005;33(4):373\u20138. https:\/\/doi.org\/10.1111\/j.1442-9071.2005.01025.x.","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"853_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1159\/000517193","volume":"244","author":"I Vasileia Chatzistergiou","year":"2021","unstructured":"Chatzistergiou V, Papasavvas I, Ambresin A, Pournaras JAC. Prediction of postoperative visual outcome in patients with idiopathic epiretinal membrane. Ophthalmologica. 2021 Dec 17;244(6):535\u201342.","journal-title":"Ophthalmologica 17 Dec"},{"issue":"3","key":"853_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/24741264241231091","volume":"8","author":"SC Drummond","year":"2024","unstructured":"Drummond SC, Crosson JN, Mason JO 3rd. Long-term outcomes of vitrectomy for idiopathic epiretinal membrane with internal limiting membrane removal in patients with good preoperative visual acuity. J Vitreoretin Dis. 2024;8(3):247\u201352. Published 22 February 2024. https:\/\/doi.org\/10.1177\/24741264241231091.","journal-title":"J Vitreoretin Dis"},{"issue":"6","key":"853_CR33","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10792-014-0010-1","volume":"34","author":"KT Kang","year":"2014","unstructured":"Kang KT, Kim KS, Kim YC. Surgical results of idiopathic and secondary epiretinal membrane. Int Ophthalmol. 2014;34(6):1227\u201332. https:\/\/doi.org\/10.1007\/s10792-014-0010-1.","journal-title":"Int Ophthalmol"},{"issue":"3","key":"853_CR34","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00417-021-05425-4","volume":"260","author":"JC Norton","year":"2022","unstructured":"Norton JC, Soliman MK, Yang YC, Kurup S, Sallam AB. Visual outcomes of primary versus secondary epiretinal membrane following vitrectomy and cataract surgery. Graefes Arch Clin Exp Ophthalmol. 2022;260(3):817\u201325. https:\/\/doi.org\/10.1007\/s00417-021-05425-4.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"853_CR35","first-page":"JOO","volume":"1","author":"H Dermer","year":"2019","unstructured":"Dermer H, Hussain RM, Lin J, Vanner EA, Haddock LJ, et al. Combined phacovitrectomy versus sequential approach in eyes with epiretinal membrane and cataract. OSP J Ophthal. 2019;1:JOO\u20131.","journal-title":"OSP J Ophthal"},{"issue":"4","key":"853_CR36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ajo.2011.09.011","volume":"153","author":"M Shimozono","year":"2012","unstructured":"Shimozono M, Oishi A, Hata M, et al. The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am J Ophthalmol. 2012;153(4):698\u2013e7041. https:\/\/doi.org\/10.1016\/j.ajo.2011.09.011.","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"853_CR37","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1167\/iovs.13-12702","volume":"54","author":"M Yuji Itoh","year":"2013","unstructured":"Itoh Y, Inoue M, Rii T, Hirota K, Hirakata A. Correlation between foveal cone outer segment tips line and visual recovery after epiretinal membrane surgery. Invest Ophthalmol Vis Sci. 2013;54(12):7302\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"853_CR38","first-page":"5760","volume":"60","author":"PR Parker","year":"2019","unstructured":"Parker PR, Zeyer JC, Mathew WMC. Thickness segmentation measurements and disorganisation of the inner retinal layers on optical coherence tomography as pre-operative indicators of visual outcome following vitrectomy with epiretinal membrane peeling. Invest Ophthalmol Vis Sci. 2019;60(9):5760.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"853_CR39","doi-asserted-by":"publisher","unstructured":"Kauffmann Y, Ramel J-C, Isaico R, De Lazzer A, Bron AM, Creuzot-Garcher C. Long-term anatomical and functional outcomes after combined cataract and idiopathic epiretinal membrane surgery. Ophthalmic Res. 2017 Feb 1;57(2):125\u2013134. https:\/\/doi.org\/10.1159\/000452837.","DOI":"10.1159\/000452837"},{"issue":"6","key":"853_CR40","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/jcm12062107","volume":"12","author":"M Romano","year":"2023","unstructured":"Romano M, Catania F, Vallejo-Garcia JL, Sorrentino T, Crincoli E, Vinciguerra P. Variability of visual recovery with time in epiretinal membrane surgery: a predictive analysis based on retinal layer OCT thickness changes. J Clin Med. 2023 Mar 8;12(6):2107. https:\/\/doi.org\/10.3390\/jcm12062107. PMID: 36983110; PMCID: PMC10059266.","journal-title":"J Clin Med 8 March"},{"issue":"1","key":"853_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","volume":"333","author":"World Medical Association","year":"2025","unstructured":"World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human participants. JAMA. 2025;333(1):71\u20134. https:\/\/doi.org\/10.1001\/jama.2024.21972.","journal-title":"JAMA"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00853-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00853-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:46:47Z","timestamp":1780530407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00853-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00853-y","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the tenets of the Declaration of Helsinki [\n                      \n                      ]. The study protocol was reviewed and approved by the ethics committee of FOLA, Santiago, Chile. Given the retrospective, observational design and the use of de-identified clinical data, the requirement for written informed consent to participate was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}